Kirsty is an associate in the Freshfields’ UK antitrust, competition and trade practice. Kirsty’s practice covers all aspects of EU and UK competition law, including cartel and behavioural investigations, market studies, merger control, foreign investment and strategic antitrust counselling.
Kirsty has experience of advising clients across a wide range of industries, including industrials, life science/healthcare and financial services sectors. Kirsty is based in London and has spent time on secondment to our Washington DC office.
back to tab navigation
- Advising AstraZeneca on its $245 million deal with Cellectis SA, aimed at speeding up the development of CAR-T treatments in areas including oncology, immunology and rare diseases.
- Advising the London Stock Exchange on its 10 year strategic partnership with Microsoft for data and analytics and cloud infrastructure solutions.
- Advising the London Stock Exchange on its $27bn acquisition of Refinitiv, a financial information, data and analytics provider, which required review by 20 antitrust authorities worldwide, including in-depth merger reviews in the EU and US, as well as foreign investment reviews in several jurisdictions.
- Advising Alpek on its $620 million acquisition of OCTAL, a manufacturer of PET resin, PET sheet and PET packaging.
- Advising a financial services client in defending allegations of multi-jurisdictional cartel conduct by the European Commission and other antitrust regulators.
back to tab navigation
- University of St Andrews (BSc (Hons) in Economics)
- BPP University (Graduate Diploma in Law and Legal Practice Course)
- Qualified as a solicitor in England and Wales
back to tab navigation
